Company Badge
USPTO Data Jan 1 1976 - Oct 27 2026
10 Patents
#23 in New Haven, CT
#634 in Connecticut
#29,892 in US
#56,119 in the World
Genaissance Pharmaceuticals, Inc.
Forward Citations = 320
24 inventors:
New Haven, CT, United States of America
Genaissance Pharmaceuticals, Inc.
Calculating rank
% Expired Patents = 60.0
Forward Citations = 320
Loading Chart...
Loading Chart...
24 inventors (with patents filed for the assignee):
Richard S Judson (4 out of 5 patents)
J Claiborne Stephens (3 out of 3 patents)
Andreas Windemuth (2 out of 7 patents)
4. Marco Guida (2 out of 5 patents)
5. Jeff Hall (2 out of 3 patents)
6. Stephen Bryant Liggett (2 out of 16 patents)
7. Krishnan Nandabalan (1 out of 18 patents)
8. Gualberto Ruaño (1 out of 2 patents)
9. R Rex Denton (1 out of 2 patents)
10. Chuanbo Xu (1 out of 1 patent)
11. William P Petros (1 out of 1 patent)
12. Oliver M Colvin (1 out of 1 patent)
13. Jeffrey R Marks (1 out of 3 patents)
14. James J Vredenburgh (1 out of 1 patent)
15. Frank H Ruddle (1 out of 7 patents)
10 patents:
Company Overview
Genaissance Pharmaceuticals, Inc. is a biotechnology company based in New Haven, Connecticut, specializing in the development of innovative genomic solutions. The organization focuses on harnessing genetic information to enhance drug discovery and development processes, aiming to improve patient outcomes through personalized medicine. Genaissance is dedicated to advancing the understanding of genetic variations and their implications in therapeutic responses, thereby contributing to the evolving landscape of precision healthcare.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Genaissance Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/genaissance-pharmaceuticals
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]